358 related articles for article (PubMed ID: 16880330)
1. Targeted disruption of the scavenger receptor and chemokine CXCL16 accelerates atherosclerosis.
Aslanian AM; Charo IF
Circulation; 2006 Aug; 114(6):583-90. PubMed ID: 16880330
[TBL] [Abstract][Full Text] [Related]
2. CXCL16/SR-PSOX is an interferon-gamma-regulated chemokine and scavenger receptor expressed in atherosclerotic lesions.
Wuttge DM; Zhou X; Sheikine Y; Wågsäter D; Stemme V; Hedin U; Stemme S; Hansson GK; Sirsjö A
Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):750-5. PubMed ID: 14988089
[TBL] [Abstract][Full Text] [Related]
3. Lentiviral vector-mediated siRNA knockdown of SR-PSOX inhibits foam cell formation in vitro.
Zhang L; Liu HJ; Li TJ; Yang Y; Guo XL; Wu MC; Rui YC; Wei LX
Acta Pharmacol Sin; 2008 Jul; 29(7):847-52. PubMed ID: 18565283
[TBL] [Abstract][Full Text] [Related]
4. Atherogenic scavenger receptor modulation in the tubulointerstitium in response to chronic renal injury.
Okamura DM; López-Guisa JM; Koelsch K; Collins S; Eddy AA
Am J Physiol Renal Physiol; 2007 Aug; 293(2):F575-85. PubMed ID: 17537985
[TBL] [Abstract][Full Text] [Related]
5. Cell surface-anchored SR-PSOX/CXC chemokine ligand 16 mediates firm adhesion of CXC chemokine receptor 6-expressing cells.
Shimaoka T; Nakayama T; Fukumoto N; Kume N; Takahashi S; Yamaguchi J; Minami M; Hayashida K; Kita T; Ohsumi J; Yoshie O; Yonehara S
J Leukoc Biol; 2004 Feb; 75(2):267-74. PubMed ID: 14634054
[TBL] [Abstract][Full Text] [Related]
6. The chemokine and scavenger receptor CXCL16/SR-PSOX is expressed in human vascular smooth muscle cells and is induced by interferon gamma.
Wågsäter D; Olofsson PS; Norgren L; Stenberg B; Sirsjö A
Biochem Biophys Res Commun; 2004 Dec; 325(4):1187-93. PubMed ID: 15555552
[TBL] [Abstract][Full Text] [Related]
7. Macrophage expression of peroxisome proliferator-activated receptor-alpha reduces atherosclerosis in low-density lipoprotein receptor-deficient mice.
Babaev VR; Ishiguro H; Ding L; Yancey PG; Dove DE; Kovacs WJ; Semenkovich CF; Fazio S; Linton MF
Circulation; 2007 Sep; 116(12):1404-12. PubMed ID: 17724261
[TBL] [Abstract][Full Text] [Related]
8. Chemokine SR-PSOX/CXCL16 expression in peripheral blood of patients with acute coronary syndrome.
Yang HL; Xu YY; DU LF; Liu CH; Zhao Q; Wei WJ; You Y; Quan ZH
Chin Med J (Engl); 2008 Jan; 121(2):112-7. PubMed ID: 18272035
[TBL] [Abstract][Full Text] [Related]
9. CXCL16 is a marker of inflammation, atherosclerosis, and acute coronary syndromes in humans.
Lehrke M; Millington SC; Lefterova M; Cumaranatunge RG; Szapary P; Wilensky R; Rader DJ; Lazar MA; Reilly MP
J Am Coll Cardiol; 2007 Jan; 49(4):442-9. PubMed ID: 17258089
[TBL] [Abstract][Full Text] [Related]
10. Enhanced expression and shedding of the transmembrane chemokine CXCL16 by reactive astrocytes and glioma cells.
Ludwig A; Schulte A; Schnack C; Hundhausen C; Reiss K; Brodway N; Held-Feindt J; Mentlein R
J Neurochem; 2005 Jun; 93(5):1293-303. PubMed ID: 15934948
[TBL] [Abstract][Full Text] [Related]
11. SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation.
Uza N; Nakase H; Yamamoto S; Yoshino T; Takeda Y; Ueno S; Inoue S; Mikami S; Matsuura M; Shimaoka T; Kume N; Minami M; Yonehara S; Ikeuchi H; Chiba T
Gut; 2011 Nov; 60(11):1494-505. PubMed ID: 21471570
[TBL] [Abstract][Full Text] [Related]
12. Chemokine CXCL10 promotes atherogenesis by modulating the local balance of effector and regulatory T cells.
Heller EA; Liu E; Tager AM; Yuan Q; Lin AY; Ahluwalia N; Jones K; Koehn SL; Lok VM; Aikawa E; Moore KJ; Luster AD; Gerszten RE
Circulation; 2006 May; 113(19):2301-12. PubMed ID: 16682613
[TBL] [Abstract][Full Text] [Related]
13. IL-18 accelerates atherosclerosis accompanied by elevation of IFN-gamma and CXCL16 expression independently of T cells.
Tenger C; Sundborger A; Jawien J; Zhou X
Arterioscler Thromb Vasc Biol; 2005 Apr; 25(4):791-6. PubMed ID: 15604417
[TBL] [Abstract][Full Text] [Related]
14. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
15. Role of macrophage scavenger receptors in diet-induced atherosclerosis in mice.
Sakaguchi H; Takeya M; Suzuki H; Hakamata H; Kodama T; Horiuchi S; Gordon S; van der Laan LJ; Kraal G; Ishibashi S; Kitamura N; Takahashi K
Lab Invest; 1998 Apr; 78(4):423-34. PubMed ID: 9564887
[TBL] [Abstract][Full Text] [Related]
16. CXCL16 is a novel mediator of the innate immunity of epidermal keratinocytes.
Tohyama M; Sayama K; Komatsuzawa H; Hanakawa Y; Shirakata Y; Dai X; Yang L; Tokumaru S; Nagai H; Hirakawa S; Sugai M; Hashimoto K
Int Immunol; 2007 Sep; 19(9):1095-102. PubMed ID: 17855433
[TBL] [Abstract][Full Text] [Related]
17. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.
Babaev VR; Yancey PG; Ryzhov SV; Kon V; Breyer MD; Magnuson MA; Fazio S; Linton MF
Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1647-53. PubMed ID: 15947238
[TBL] [Abstract][Full Text] [Related]
18. High levels and inflammatory effects of soluble CXC ligand 16 (CXCL16) in coronary artery disease: down-regulatory effects of statins.
Smith C; Halvorsen B; Otterdal K; Waehre T; Yndestad A; Fevang B; Sandberg WJ; Breland UM; Frøland SS; Oie E; Gullestad L; Damås JK; Aukrust P
Cardiovasc Res; 2008 Jul; 79(1):195-203. PubMed ID: 18339644
[TBL] [Abstract][Full Text] [Related]
19. Attenuated expression of profilin-1 confers protection from atherosclerosis in the LDL receptor null mouse.
Romeo GR; Moulton KS; Kazlauskas A
Circ Res; 2007 Aug; 101(4):357-67. PubMed ID: 17615372
[TBL] [Abstract][Full Text] [Related]
20. P55 tumour necrosis factor receptor in bone marrow-derived cells promotes atherosclerosis development in low-density lipoprotein receptor knock-out mice.
Xanthoulea S; Gijbels MJ; van der Made I; Mujcic H; Thelen M; Vergouwe MN; Ambagts MH; Hofker MH; de Winther MP
Cardiovasc Res; 2008 Nov; 80(2):309-18. PubMed ID: 18628255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
